Pa-One, Thanks for your question. Have a look at my previous posts on various threads here for more detail, but essentially, the TGA approval is great for the local market, but Australia is 1% of the world pharma market. All international approvals (and our success in partnering Nasodine) will depend on the results of the current Phase 3 trial. Long term value creation relies on Nasodine becoming a successful global product. PM
FRE Price at posting:
17.5¢ Sentiment: None Disclosure: Held
